It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The global spread of coronavirus disease (COVID-19) has escalated the need for public sanitation. Ultraviolet (UV) light is a well-established antimicrobial; however, the UV light commonly used for this purpose (~254 nm) poses significant health risks in public spaces due to its cancer-causing effects. Far-UVC light (~207-222 nm) has similar germicidal properties without health risks, as it does not penetrate human eye or skin cells. This group previously found low doses of far-UVC light (222 nm) to be an effective germicide against aerosolized H1N1 influenza virus. In this study, the researchers tested two viruses that are closely related to SARS-CoV-2, the virus that causes COVID-19. Because the sensitivity of a virus to UV is determined by its genome size and all coronaviruses have genomes of similar sizes, it is reasonable to expect the sensitivity of SARS-CoV-2 to be comparable to these viruses.The authors tested several doses of far-UVC on aerosolized viruses. They found that for both viruses tested, 99.9% of the virus was inactivated at a lower dose than the one needed to inactivate H1N1 virus. The authors also suggested a safe dose for an 8-hour work shift based on recommendations from the International Commission on Non-Ionizing Radiation Protection (ICNIRP). At this dose, 90% of aerosolized viruses would be deactivated in 8 minutes, 95% in 16 minutes, and 99% in 25 minutes. These results combined with the earlier results for H1N1 suggest that low doses of far-UVC light in heavily occupied spaces would reduce the spread of viral diseases, likely including COVID-19.
Learn more about Research Highlights
View Research Highlight
A direct approach to limit airborne transmission of pathogens is to inactivate them within a short time of their production. Germicidal ultraviolet light (UV), typically at 254 nm, is effective in this context, but it is a health hazard to the skin and eyes. By contrast, far-UVC light (207-222 nm) efficiently kills pathogens without harm to exposed human cells or tissues. We previously demonstrated that 222-nm UV light efficiently kills airborne influenza virus (H1N1); here we extend the far-UVC studies to explore efficacy against human coronaviruses from subgroups alpha (HCoV-229E) and beta (HCoV-OC43). We found that low doses of, respectively 1.7 and 1.2 mJ/cm2 inactivated 99.9% of aerosolized alpha coronavirus 229E and beta coronavirus OC43. Based on these results for the beta HCoV-OC43 coronavirus, continuous far-UVC exposure in public locations at the currently recommended exposure limit (3 mJ/cm2/hour) would result in 99.9% viral inactivation in ~ 25 minutes. Increasing the far- UVC intensity by, say, a factor of 2 would halve these disinfection times, while still maintaining safety. As all human coronaviruses have similar genomic size, a key determinant of radiation sensitivity, it is realistic to expect that far-UVC light will show comparable inactivation efficiency against other human coronaviruses, including SARS-CoV-2.
Visual Abstract
visual abstract
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer